Logo image of RCS

PIMCO STRATEGIC INCOME FUND (RCS) Stock Price, Quote, News and Overview

NYSE:RCS - New York Stock Exchange, Inc. - US72200X1046 - Currency: USD

5.6  +0.16 (+2.94%)

Fundamental Rating

1

RCS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. RCS has a bad profitability rating. Also its financial health evaluation is rather negative. RCS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

RCS had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: RCS reported negative net income in multiple years.
In multiple years RCS reported negative operating cash flow during the last 5 years.
RCS Yearly Net Income VS EBIT VS OCF VS FCFRCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 3.08%
ROE 13.58%
ROIC 4.07%
ROA(3y)-0.44%
ROA(5y)-0.22%
ROE(3y)-0.97%
ROE(5y)-0.44%
ROIC(3y)4.67%
ROIC(5y)4.72%
RCS Yearly ROA, ROE, ROICRCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

In the last couple of years the Profit Margin of RCS has remained more or less at the same level.
In the last couple of years the Operating Margin of RCS has declined.
In the last couple of years the Gross Margin of RCS has declined.
Industry RankSector Rank
OM 64.14%
PM (TTM) 104.03%
GM 64.18%
OM growth 3Y-5.15%
OM growth 5Y-3.89%
PM growth 3YN/A
PM growth 5Y-1.36%
GM growth 3Y-5.16%
GM growth 5Y-3.89%
RCS Yearly Profit, Operating, Gross MarginsRCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

1

2. Health

2.1 Basic Checks

The number of shares outstanding for RCS has been increased compared to 1 year ago.
The number of shares outstanding for RCS has been increased compared to 5 years ago.
RCS has a better debt/assets ratio than last year.
RCS Yearly Shares OutstandingRCS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
RCS Yearly Total Debt VS Total AssetsRCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

RCS has an Altman-Z score of -0.47. This is a bad value and indicates that RCS is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.60 indicates that RCS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACCN/A
RCS Yearly LT Debt VS Equity VS FCFRCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

RCS has a Current Ratio of 0.39. This is a bad value and indicates that RCS is not financially healthy enough and could expect problems in meeting its short term obligations.
RCS has a Quick Ratio of 0.39. This is a bad value and indicates that RCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
RCS Yearly Current Assets VS Current LiabilitesRCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

1

3. Growth

3.1 Past

RCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 149.62%, which is quite impressive.
The earnings per share for RCS have been decreasing by -10.14% on average. This is quite bad
The Revenue for RCS has decreased by -13.11% in the past year. This is quite bad
Measured over the past years, RCS shows a decrease in Revenue. The Revenue has been decreasing by -8.01% on average per year.
EPS 1Y (TTM)149.62%
EPS 3YN/A
EPS 5Y-10.14%
EPS Q2Q%4882.19%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y-13.5%
Revenue growth 5Y-8.01%
Sales Q2Q%4.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCS Yearly Revenue VS EstimatesRCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.33, the valuation of RCS can be described as very reasonable.
RCS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
Industry RankSector Rank
PE 9.33
Fwd PE N/A
RCS Price Earnings VS Forward Price EarningsRCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCS Per share dataRCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

RCS has a Yearly Dividend Yield of 9.23%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.47, RCS pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.23%

5.2 History

RCS has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of RCS decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
RCS Yearly Dividends per shareRCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of RCS are negative and hence is the payout ratio. RCS will probably not be able to sustain this dividend level.
DP-44.7%
EPS Next 2YN/A
EPS Next 3YN/A
RCS Yearly Income VS Free CF VS DividendRCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

PIMCO STRATEGIC INCOME FUND

NYSE:RCS (4/25/2025, 8:04:00 PM)

5.6

+0.16 (+2.94%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.62%
Inst Owner Change-37.07%
Ins OwnersN/A
Ins Owner Change0%
Market Cap260.18M
Analysts0
Price TargetN/A
Short Float %1.57%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield 9.23%
Yearly Dividend0.54
Dividend Growth(5Y)N/A
DP-44.7%
Div Incr Years0
Div Non Decr Years2
Ex-Date04-11 2025-04-11 (0.04)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.33
Fwd PE N/A
P/S 9.92
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)0.6
EY10.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.56
BVpS4.32
TBVpS4.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.08%
ROE 13.58%
ROCE 8.12%
ROIC 4.07%
ROICexc 4.07%
ROICexgc 4.18%
OM 64.14%
PM (TTM) 104.03%
GM 64.18%
FCFM N/A
ROA(3y)-0.44%
ROA(5y)-0.22%
ROE(3y)-0.97%
ROE(5y)-0.44%
ROIC(3y)4.67%
ROIC(5y)4.72%
ROICexc(3y)4.67%
ROICexc(5y)4.73%
ROICexgc(3y)4.9%
ROICexgc(5y)4.92%
ROCE(3y)10.1%
ROCE(5y)10.16%
ROICexcg growth 3Y-6.49%
ROICexcg growth 5Y13.5%
ROICexc growth 3Y-6.98%
ROICexc growth 5Y12.98%
OM growth 3Y-5.15%
OM growth 5Y-3.89%
PM growth 3YN/A
PM growth 5Y-1.36%
GM growth 3Y-5.16%
GM growth 5Y-3.89%
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -0.47
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)149.62%
EPS 3YN/A
EPS 5Y-10.14%
EPS Q2Q%4882.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y-13.5%
Revenue growth 5Y-8.01%
Sales Q2Q%4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.39%
EBIT growth 3Y-17.96%
EBIT growth 5Y-11.59%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.92%
FCF growth 3Y8.41%
FCF growth 5Y76.67%
OCF growth 1Y43.92%
OCF growth 3Y8.41%
OCF growth 5Y76.67%